Pauric McPhillips

Pauric McPhillips

Total lobbying returns involving this official: 122

Connections GraphMethod Pie

Official Profile

Most Recent Title
Special Advisor to the Tanaiste
Most Recent Public Body
Department of the Taoiseach
First Seen
11 September 2017
Last Seen
20 September 2025

Observed Titles

Adviser to MinisterSpecial AdviserSpecial AdvisorSpecial Advisor to the Tanaiste

Observed Public Bodies

Department of Business, Enterprise and InnovationDepartment of Culture, Heritage and the GaeltachtDepartment of Foreign AffairsDepartment of Jobs, Enterprise and InnovationDepartment of Rural and Community DevelopmentDepartment of Social ProtectionDepartment of the Taoiseach
All Lobbyists
Select methods...

Lobbying Records (Page 1 of 13)

Current/Former DPOFAQ

Intent: Raise awareness about Explorium’s visitor numbers in its first year of reopening, outline new programmes and initiatives planned in the coming months, and highlight Explorium’s potential as a national resource.

Details: Letter to request meeting to discuss Explorium’s positive role in science education for children and young people and to highlight Explorium's potential as a national resource.

Methods
Informal communicationLetter

Intent: Support for delivery of the hydrogen strategy and providing operational supports for biomethane producers.

Details: Pathway briefing on our plans to decarbonise the network

Methods
In-person meeting, 16th June - Meeting

Intent: Attended the Joint Oireachtas Committee on Social Protection to discuss our Pre Budget Submission 2026, and to answer questions from the Committee Members

Details: Pre-Budget Submission 2026

Methods
Attended the Joint Oireachtas Committee on Social Protection to discuss our Pre Budget Submission 2026, and to answer questions from the Committee Members - Lobby day

Pfizer

2025-05-21

Intent: To highlight that tariffs on medicines and their inputs would increase healthcare costs for patients and increase the cost of producing medicines, reducing the competitiveness of pharmaceutical manufacturers that drive innovation. Globally integrated supply chains for medicines means that the impact of tariffs cannot be limited to one country. ::Ensuring pharmaceuticals are exempt from any potential retaliatory tariffs because suchmeasures have a cumulative negative impact, increasing the cost of production andreducing patient access.

Details: Raise concern about the impact of potential tariffs on pharmaceutical manufacturing and supply of medicines to patients globally

Methods
EmailMeetingPhone call

Q4PR

2025-05-21
Current/Former DPOFAQ

Intent: Discuss concerns about State/CRU connections policy

Details: Raise awareness of concerns of digital sector re State/CRU connections policy

Methods
Phone call